Adverse effects of antiarrhythmic drugs in patients with atrial fibrillation in Primary Care;Estudio sobre los efectos adversos de los fármacos antiarrítmicos en pacientes con fibrilación auricular atendidos en un Centro de Atención Primaria

Medicina Clinica

Volumn 137, Issue 6, 2011, Pages 241-246

  Benito, Luisa ^a   Hoyo, Jordi ^a   Montroig, Àngels ^a   Fornés, Berta ^a   Fluxà, Guillem ^a   Martí, David ^a   Pedrós, Montserrat ^b   Sisó, Antoni ^a   Mont, Lluís ^c   Miró, Scar ^c,d   Coll Vinent, Blanca ^c,d  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b IQVIA   (United States)

^c HOSPITAL CLÍNIC   (Spain)

^d Grupo de Investigación Urgencias Procesos y Patologías   (Spain)

Author keywords

Adverse effects; Antiarrhythmic drugs; Atrial fibrillation; Primary Care

Indexed keywords

AMIODARONE; BISOPROLOL; DIGOXIN; SOTALOL;

ARTICLE; BRADYCARDIA; DIAGNOSTIC PROCEDURE; HEALTH SERVICE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HOSPITALIZATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LABORATORY TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BRADYCARDIA; COMORBIDITY; EDEMA; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SPAIN;

EID: 80051551299     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.06.034     Document Type: Article

References (29)

1. K.M. Ryder, and E.J. Benjamin Epidemiology and significance of atrial fibrillation Am J Cardiol 84 1999 131R 138R
2. W.M. Feinberg, J.L. Blackshear, A. Laupacis, R. Kronmal, and R.G. Hart Prevalence, age, distribution and gender of patients with atrial fibrillation Arch Intern Med 155 1995 469 473
3. E. Vázquez, J. Muñoz, C. Lozano, A. Ramírez, M. Guzmán, and A. Tarabini Análisis de la frecuencia de las arritmias cardíacas y de los trastornos de conducción desde una perspectiva asistencial Rev Esp Cardiol 58 2005 657 665
4. A.D. Krahn, J. Manfreda, R.B. Tate, F.A. Mathewson, and T.E. Cuddy The natural history of atrial fibrillation: Incidence, risk factors and prognosis in the Manitoba Follow-Up Study Am J Med 98 1995 476 484
5. W.B. Kannel, R.D. Abbott, D.D. Savage, and P.M. McNamara Epidemiologic features of chronic atrial fibrillation: the Framingham Study N Engl J Med 306 1982 1018 1022 (Pubitemid 12155370)
6. D.G. Wyse, A.L. Waldo, J.P. DiMarco, M.J. Domanski, Y. Rosenberg, E.B. Schron Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833 (Pubitemid 35417773)
7. I.C. Van Gelder, V.E. Hagens, H.A. Bosker, J.H. Kingma, O. Kamp, T. Kingma Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840 (Pubitemid 35417774)
8. P.E. Vardas, and E.M. Kallergis Drug therapy for atrial fibrillation Expert Opin Pharmacother 7 2006 1121 1131 (Pubitemid 43958352)
9. A.J. Camm Safety considerations in the farmacological management of atrial fibrillation Int J Cardiol 127 2008 299 306
10. E.S. Kaufman, P.A. Zimmermann, T. Wang, G.W. Dennish 3rd, P.D. Barrell, and M.L. Chandler Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis J Am Coll Cardiol 44 2004 1276 1282 (Pubitemid 39208885)
11. J.W. Schrickel, J.O. Schwab, A. Yang, A. Bitzen, B. Lüderitz, and T. Lewalter Torsade de pointes in patients with structural heart disease and atrial fibrillation treated with amiodarone, beta-blockers, and digitalis Pacing Clin Electrophysiol 29 2006 363 366
12. E.L. Batcher, X.C. Tang, B.N. Singh, S.N. Singh, D.J. Reda, and J.M. Hershman Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation Am J Med 120 2007 880 885 (Pubitemid 47451295)
13. P. Hallberg, J. Lindback, B. Lindahl, U. Stenestrand, H. Melhus RIKS-HIA group Digoxin and mortality in atrial fibrillation: a prospective cohort study Eur J Clin Pharmacol 63 2007 959 971 (Pubitemid 47387912)
14. K.H. Humphries, C.R. Kerr, M. Steinbuch, P. Dorian Canadian Registry of Atrial Fibrillation investigators Limitations to antiarrhythmic drug use in patients with atrial fibrillation CMAJ 171 2004 741 745 (Pubitemid 39319091)
15. T. Rudo, and P. Kowey Atrial fibrillation: choosing an antiarrhythmic drug Curr Cardiol Rep 8 2006 370 376 (Pubitemid 44445924)
16. A. Ringborg, R. Nieuwlaat, P. Lindgren, B. Jönsson, D. Fidan, and A.P. Maggioni Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation Europace 10 2008 403 411 (Pubitemid 351767678)
17. C.A. Naranjo, U. Busto, E.M. Sellers, P. Sandor, I. Ruiz, and E.A. Roberts A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 30 1981 239 245 (Pubitemid 12149145)
18. E.M. Vaughan Williams A classification of antiarrhythmic actions reassessed after a decade of new drugs J Clin Pharmacol 24 1984 129 147 (Pubitemid 14108816)
19. V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, A.B. Curtis, and K.A. Ellenbogen ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace 8 2006 651 745 (Pubitemid 44472247)
20. Panel del Consenso del Grupo de Arritmias de la Sociedad Española de Medicina de Urgencias y Emergencias (SEMES) y la Sección de Electrofisiología de la Sociedad Española de Cardiología (SEC) Guías para el manejo de la fibrilación auricular en los servicios de urgencias hospitalarios Emergencias 14 2002 243 261
21. D. Roy, M. Talajic, S. Nattel, D.G. Wyse, P. Dorian, and K.L. Lee Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677 (Pubitemid 351860859)
22. B. Coll-Vinent, M. Junyent, J. Orus, C. Villarroel, J. Casademont, and O. Miro Tratamiento de la fibrilación auricular en los distintos niveles asistenciales de un área sanitaria Med Clin (Barc) 128 2007 125 129 (Pubitemid 46382334)
23. B. Coll-Vinent, G. Pacheco, M. Junyent, L. Benito, J. Hoyo, and A. Garcia Impacto de la instauración de un protocolo común en los distintos niveles asistenciales de un área sanitaria para la mejora del tratamiento de la fibrilación auricular Rev Esp Cardiol 60 2007 392 403 (Pubitemid 46881544)
24. L. Testa, R. Bhindi, and A.P. Banning Digitalis: a dangerous drug in atrial fibrillation? Heart 94 2008 1654
25. D. Roy, C.M. Pratt, C. Torp-Pedersen, D.G. Wyse, E. Toft, S. Juul-Moller Atrial Arrhythmia Conversion Trial Investigators Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial Circulation 117 2008 1518 1525 (Pubitemid 351440640)
26. D. Kozlowski, S. Budrejko, G.Y. Lip, D.P. Mikhailidis, J. Rysz, and G. Raczak Vernakalant hydrochloride for the treatment of atrial fibrillation Expert Opin Investig Drugs 18 2009 1929 1937
27. J.Y. Le Heuzey, G.M. De Ferrari, D. Radzik, M. Santini, J. Zhu, and J.M. Davy A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study J Cardiovasc Electrophysiol 21 2010 597 605
28. J.P. Piccini, V. Hasselblad, E.D. Peterson, J.B. Washam, R.M. Califf, and D.F. Kong Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation J Am Coll Cardiol 54 2009 1089 1095
29. S.H. Hohnloser, H.J. Crijns, M. Van Eickels, C. Gaudin, R.L. Page, C. Torp-Pedersen ATHENA Investigators Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678